Capital Flow Monitor · Sponsors · CIK 1901628
Gameto, Inc.
12117 Bee Caves Road, Bee Cave, TX, 78738 · 929-930-9669
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$44.0M
Sold
$44.0M
% sold
100.0%
Investors
22
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-26 | D ·current | 506(b) | $44.0M | $44.0M | 100.0% | 22 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Martin Varsavsky — Executive Officer / Director, Bee Cave, TX
- Dina Radenkovic — Executive Officer / Director, Bee Cave, TX
-
Jonathan Hostens — Director, Bee Cave, TX
1 other raise
- NanoMosaic Inc. $3.0M of $5.0M · 60.4%
-
Maryanna Saenko — Director, Bee Cave, TX
3 other raises
- Future Ventures PNT 1, LLC $78.3M of $78.3M · 100.0%
- Cambrian BioPharma Inc $123.8M of $129.8M · 95.4%
- Future Ventures Commonwealth Fusion Fund II, LLC $19.6M of $19.6M · 100.0%
-
Dusan Perovic — Director, Bee Cave, TX
8 other raises
- Deviation Co-Invest LLC - Deviate IV $447K of $447K · 100.0%
- Deviation Co-Invest LLC - Deviate V $913K of $913K · 100.0%
- Deviation Co-Invest LLC - Deviate III $828K of $828K · 100.0%
- Deviation Co-Invest LLC - Deviate II $10.3M of $10.3M · 100.0%
- Deviation Co-Invest LLC - Deviate I $6.2M of $6.2M · 100.0%
- Human Biotech, Inc. $10.0M of $10.0M · 100.0%
- Deviation Capital V LP $0 of —
- Freeform Future Corp. $58.9M of $67.1M · 87.8%
-
Kristina Simmons — Director, Bee Cave, TX
1 other raise
- Overwater Ventures SPV III, L.P. $15.0M of $15.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.